Revolutionizing Diabetes Management: Microbead Formulation of Low-Soluble Antidiabetic Drugs for Enhanced Therapeutic Efficacy

Abstract

This review delves into the intersection of antidiabetic drugs and microbeads, exploring their potential synergy in overcoming pharmaceutical limitations. Diabetes mellitus, a chronic metabolic disorder characterized by elevated blood glucose levels, demands comprehensive management strategies, with antidiabetic drugs forming a cornerstone in this approach. Microbeads, innovative carriers for these drugs, provide solutions to challenges like low solubility and erratic bioavailability. Ranging from tens to hundreds of micrometers, microbeads offer a versatile platform for controlled and sustained drug release, crafted from biocompatible polymers like alginate, chitosan, or synthetic materials such as PLA and PLGA.

The narrative navigates through diabetes management intricacies, diverse antidiabetic medications, and the captivating realm of microbeads. From ionotropic gelation to emulsion-solvent evaporation, formulation techniques offer possibilities for optimizing drug delivery. The promise of microbeads in revolutionizing drug delivery becomes evident, addressing challenges of low solubility and enhancing stability. The review unravels multidimensional aspects, shedding light on the potential contributions of microbeads to advancing pharmacotherapy in low-soluble diabetic drugs. The exploration of this dynamic intersection holds promise for the future of diabetic care and drug delivery innovation.